Risk and special populations
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
identifying factors
32233642 2020. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus
32232218 2020. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis
32304772 ä. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China
32118640 ä. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
Frailty
32268300 2020. Biomarkers of biological age as predictors of COVID-19 disease severity
32339960 2020. Clinical characteristics of older patients infected with COVID-19: A descriptive study
32331795 ä. Afectacion clinica y sintomatoligica en pacientes mayores de 65 anos por COVID-19
32269670 2020. Canadian Geriatrics Society COVID-19 Recommendations for Older Adults What Do Older Adults Need To Know?
Comorbidity
32267833 2020. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
Diabetes, Obesity, low androgens
32249357 ä. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic
32345580 2020. Diabetes and covid-19: a global health challenge
32345579 2020. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
Heart
32331955 ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
32326691 2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
32277299 2020. Perspective: cardiovascular disease and the Covid-19 pandemic
32335068 ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock
Kidney, Hemodialysis
32240718 ä. COVID-19 in Hemodialysis Patients: A Report of 5 Cases
32276031 ä. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle
Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak
On immunomodulators: rheumatic, transplant, dermatology, neurology
32264666 2020. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
32363045 ä. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients
HIV
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
other pharmacology
Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic
indoor livin ppl
Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations
32371563 2020. Asthma increases risk of severity of COVID-19
32360479 ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases
32360811 ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32271368 ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
32270178 ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?
32337584 ä. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit
32304745 ä. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China
32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
32376643 2020. Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women
32357998 2020. Cardiac considerations in patients with COVID-19
32332038 2020. Asthma and COVID-19
32291526 2020. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
32350632 2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty
32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
32247213 2020. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
32298981 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32334395 ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression?
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32256705 2020. Associations between immune-suppressive and stimulating drugs and novel COVID-19?a systematic review of current evidence
32328575 ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection
32322805 ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV
32372857 2020. COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: ?what the bleep do we know??
32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China
32324118 2020. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States
32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment
32232395 ä. Initial COVID-19 affecting cardiac patients in China
32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
32328850 ä. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening
32322046 ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China
32296994 ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32345527 ä. Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence
32217650 2020. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
32269088 2020. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
32341104 2020. Cardiovascular comorbidity and its impact on patients with Covid-19
32350104 ä. COVID-19 and Nicotine as a Mediator of ACE-2
32341101 2020. COVID-19 and Smoking Is Nicotine the Hidden Link?
32312864 ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019
32279905 ä. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection
32284245 ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??
32317180 ä. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China
32345072 2020. The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients
32222253 2020. COVID-19: lessons from the Italian reproductive medical experience
32323577 ä. What the oncologist needs to know about COVID-19 infection in cancer patients
32357575 2020. COVID-19: A Geriatric Emergency
32357582 2020. Ageing and COVID-19: What is the Role for Elderly People?
32274617 2020. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
32199996 2020. Infection par le SARS-CoV-2 chez les femmes enceintes: etat des connaissances et proposition de prise en charge par CNGOF
32244059 ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes
32302703 ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
32292696 ä. COVID-19 Infection Unmasking Brugada Syndrome
32277387 ä. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
32325028 ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost?
32341442 ä. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors?lessons from available evidence and insights into COVID-19
32342146 ä. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?
32342336 ä. Prevention and Control of COVID-19 in Chronic Kidney Disease
32146921 ä. COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020
32336303 ä. Risk factors for severe COVID-19 illness in healthcare workers: Too many unknowns
32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?
32173574 2020. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
32335339 ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count
32331343 2020. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?
32222883 ä. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
32125452 ä. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
32297089 ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
32361701 2020. COVID-19 Rapid Guideline in Kidney Transplant Recipients
32333915 ä. Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2
C7152876 ä. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
32371047 ä. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic
32224277 2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology
32199889 2020. Should biologics for psoriasis be interrupted in the era of COVID-19?
32283234 ä. Biologics for psoriasis during COVID-19 outbreak
32246966 ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution
C7160444 ä. Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic
32330632 ä. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment
32305444 ä. COVID-19 and racial disparities
32283235 ä. Various forms of skin rash in COVID-19 : a reply
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection
32330545 ä. African American COVID-19 Mortality: A Sentinel Event
32305401 ä. Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System
32154911 2020. COVID?19 Presents High Risk to Older Persons
32233753 2020. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
32347144 2020. Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors
32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
32370269 2020. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?
32244852 2020. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
32302955 2020. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19
32303756 ä. Impact of anti-tnf? antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases
32222956 ä. Prevalence and impact of diabetes among people infected with SARS-CoV-2
32299654 ä. The first case of COVID-19 infection in a 75-day-old infant in Jahrom City, south of Iran
32300796 ä. A geroscience perspective on COVID-19 mortality
32279081 ä. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study
32360995 ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease
32278005 ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study
32348791 ä. Clinical characteristics of COVID-19 patients with abnormal liver tests
32348790 ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
32305291 ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury
32240670 2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
32171866 ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
32335173 ä. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
32335169 ä. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
32305490 ä. Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients
32305487 ä. Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China
32269087 ä. Novel Coronavirus Infection in Newborn Babies Under 28 Days in China
32335336 2020. SARS-CoV-2: Is it the newest spark in the TORCH? Covid19 in neonates
32305459 2020. Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report
32198004 ä. A Patient with SARS-CoV-2 Infection during Pregnancy in Qingdao, China
32147409 ä. Are children less susceptible to COVID-19?
32272142 ä. More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19
32366317 2020. Covid-19?The real role of NSAIDs in Italy
32298645 ä. Neonatal COVID-19: little evidence and the need for more information?
32318729 ä. Fever without a source in a young infant due to SARS-CoV-2
32306369 ä. The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities
32244166 2020. Why are pregnant women susceptible to COVID-19? An immunological viewpoint
32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis
| 32335512 2020. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs |
32373791 ä. Sex Differences in Mortality from COVID-19 Pandemic: Are Men Vulnerable and Women Protected?
32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32215581 2020. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn
32058570 2020. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China
32352491 ä. Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection
32250385 2020. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
32320003 ä. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
32167524 ä. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
{{tp|p=32302293|t=2020. COVID-19 in older adults: clinical, psychosocial, and public health considerations |pdf=|usr=}
32247631 2020. Kidney disease is associated with in-hospital death of patients with COVID-19
32354637 ä. COVID-19 infection in kidney transplant recipients
32354634 ä. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
32363253 ä. SARS-CoV-2 Infection in Hospitalized Patients with Kidney Disease
32292865 2020. COVID-19 and the Renin-Angiotensin System
32353326 2020. Atypical presentation of COVID-19 in young infants
32151335 2020. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
32151334 2020. What are the risks of COVID-19 infection in pregnant women?
32035511 2020. 2019-nCoV epidemic: what about pregnancies?
32278370 2020. The gendered dimensions of COVID-19
32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
32359411 ä. COVID-19 and obesity?lack of clarity, guidance, and implications for care
32151318 2020. Managing neonates with respiratory failure due to SARS-CoV-2 ? Authors reply
32151320 2020. Managing neonates with respiratory failure due to SARS-CoV-2
32339474 ä. Determining risk factors for mortality in liver transplant patients with COVID-19
32278366 ä. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy
32171057 2020. Implications of COVID-19 for patients with pre-existing digestive diseases
32304642 ä. COVID-19 in patients with HIV: clinical case series
32224304 2020. COVID-19 infection in children
32142639 ä. Guidelines for pregnant women with suspected SARS-CoV-2 infection
32171067 2020. Sex difference and smoking predisposition in patients with COVID-19
32171062 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
32332856 ä. COVID-19 in persons with haematological cancers
32353398 ä. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China
32344304 ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease
32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan
| 32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland |
32339915 ä. Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
32315980 2020. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
32348641 ä. Covid-19 in Immune-Mediated Inflammatory Diseases ? Case Series from New York
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32227760 ä. Renin?Angiotensin?Aldosterone System Inhibitors in Patients with Covid-19
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32237670 ä. An Uncomplicated Delivery in a Patient with Covid-19 in the United States
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32246101 ä. Controversies of renin?angiotensin system inhibition during the COVID-19 pandemic
32358609 ä. The COVID-19 outbreak and the angiotensin-converting enzyme 2: too little or too much?
32222703 ä. COVID-19 Infection in a Patient with End-Stage Kidney Disease
32197096 ä. COVID-19 in pregnant women ? Authors reply
32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32161408 2020. Lack of maternal?fetal SARS-CoV-2 transmission
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32231328 ä. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32203970 ä. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
32311696 ä. Comment on ?Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade?
32371550 2020. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19
32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan
| 32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland |
32339915 ä. Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
32315980 2020. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
32348641 ä. Covid-19 in Immune-Mediated Inflammatory Diseases ? Case Series from New York
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32227760 ä. Renin?Angiotensin?Aldosterone System Inhibitors in Patients with Covid-19
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32237670 ä. An Uncomplicated Delivery in a Patient with Covid-19 in the United States
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32246101 ä. Controversies of renin?angiotensin system inhibition during the COVID-19 pandemic
32358609 ä. The COVID-19 outbreak and the angiotensin-converting enzyme 2: too little or too much?
32222703 ä. COVID-19 Infection in a Patient with End-Stage Kidney Disease
32197096 ä. COVID-19 in pregnant women ? Authors reply
32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32161408 2020. Lack of maternal?fetal SARS-CoV-2 transmission
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32231328 ä. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32203970 ä. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
32311696 ä. Comment on ?Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade?
32371550 2020. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19
32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan
| 32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland |
32339915 ä. Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
32315980 2020. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
32348641 ä. Covid-19 in Immune-Mediated Inflammatory Diseases ? Case Series from New York
32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
32227760 ä. Renin?Angiotensin?Aldosterone System Inhibitors in Patients with Covid-19
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32237670 ä. An Uncomplicated Delivery in a Patient with Covid-19 in the United States
32265531 ä. COVID-19 and cancer: what we know so far
32346090 ä. Does asthma make COVID-19 worse?
32246101 ä. Controversies of renin?angiotensin system inhibition during the COVID-19 pandemic
32358609 ä. The COVID-19 outbreak and the angiotensin-converting enzyme 2: too little or too much?
32222703 ä. COVID-19 Infection in a Patient with End-Stage Kidney Disease
32197096 ä. COVID-19 in pregnant women ? Authors reply
32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology
32161408 2020. Lack of maternal?fetal SARS-CoV-2 transmission
32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
32231328 ä. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32203970 ä. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
32311696 ä. Comment on ?Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade?
32371550 2020. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epilepticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19
32372822 2020. Why are ethnic minorities worse affected?
32372818 2020. Men hit harder by covid-19
32372803 2020. Children and covid-19
32243722 2020. Lessons unfolding from pediatric cases of COVID?19 disease caused by SARS?CoV?2 infection
32304747 2020. Angiotensin receptor blockers and COVID-19
32360482 2020. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
32298273 2020. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study
32343745 2020. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients
32231171 2020. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis
32329978 2020. Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients
32343807 ä. The Elderly & COVID-19: Cocooning or Culling: - the choice is ours
32219440 ä. Are certain drugs associated with enhanced mortality in COVID-19?
32289171 ä. Cardiac drugs and outcome in COVID-19: Reply
32289168 ä. Cardiac drugs and outcome in COVID - 19
C7129713 ä. Coronavirus: la emergencia geri�trica de 2020 Documento conjunto de la Secci�n de Cardiolog�a Geri�trica de la Sociedad Espa�ola de Cardiolog�a y la Sociedad Espa�ola de Geriatr�a y Gerontolog�a
C7151242 ä. Controversy regarding ACE inhibitors / ARBs in Covid-19
32331829 ä. Smoking and coronavirus disease 2019 (COVID-19)
32362357 ä. Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
32314010 ä. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
32346493 ä. Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates
32335406 ä. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19
32336968 2020. COVID-19 outbreak impact in Spain: A role for tobacco smoking?
32206052 2020. COVID-19 and smoking: A systematic review of the evidence
32355638 ä. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
32154135 2020. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
32247017 ä. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy
32314274 ä. Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women
32050635 2020. Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
32204755 2020. SARS-CoV-2 infection with gastrointestinal symptoms as the first manifestation in a neonate
32377677 ä. COVID-19 in Older People: A Rapid Clinical Review
32371056 ä. Care of critically ill pregnant patients with coronavirus disease 2019: a case series
32228252 2020. COVID-19, ACE2, and the cardiovascular consequences
32277845 2020. Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates
32259279 2020. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies
32356302 2020. Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations
32141062 2020. Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?
32212348 2020. Why is COVID-19 so mild in children?
32339307 2020. Additional hypotheses about why COVID-19 is milder in children than adults
32279351 2020. We urgently need guidelines for managing COVID-19 in children with comorbidities
32310898 2020. Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome
32186894 2020. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis
32348598 2020. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient
32359205 2020. 2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases
32358994 2020. Asthma and COVID-19: is asthma a risk factor for severe outcomes?
32311145 2020. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience
32243621 2020. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient
32267016 2020. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)
32380564 2020. Caring for Pregnant Patients with COVID-19: Practical Tips Getting from Policy to Practice
32217113 2020. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
32359227 2020. Neonatal Late Onset Infection with Severe Acute Respiratory Syndrome Coronavirus 2
32359226 2020. COVID-19 and Neonatal Respiratory Care: Current Evidence and Practical Approach
32268381 2020. Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspected or Confirmed SARS-CoV-2 Infection
32305046 2020. Severe COVID-19 during Pregnancy and Possible Vertical Transmission
32330970 2020. Successful Treatment of Preterm Labor in Association with Acute COVID-19 Infection
32233067 ä. COVID?19 in kidney transplant recipients
32233057 ä. Novel Coronavirus?19 (COVID?19) in the immunocompromised transplant recipient: #Flatteningthecurve
32198834 ä. Case report of COVID?19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?
32181990 ä. Successful recovery of COVID?19 pneumonia in a renal transplant recipient with long?term immunosuppression
32243698 ä. Immunosuppression drug?related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis
32329629 2020. Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2
32378314 2020. Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options
32368838 2020. Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single center cohort of kidney recipients
32359210 2020. Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report
32243690 2020. A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China
32243697 2020. COVID-19 in posttransplant patients-report of 2 cases
32243673 2020. Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient
32324331 2020. COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine
32243672 2020. SARS Cov-2 infection in a renal-transplanted patient: A case report
32351040 2020. COVID-19 in kidney transplant recipients
32337859 2020. Two distinct cases with COVID-19 in kidney transplant recipients
32337790 2020. Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics
32330356 2020. Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States
32330343 2020. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
32319218 2020. A Case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant
32315122 2020. COVID-19 in a High-Risk Dual Heart and Kidney Transplant Recipient
32301155 2020. COVID-19 in solid organ transplant recipients: A single-center case series from Spain
32282991 2020. Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report
32282986 2020. Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients
32277555 2020. Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report
32282977 2020. First case of COVID-19 in a kidney transplant recipient treated with belatacept
32277591 2020. Fatal outcome in a liver transplant recipient with COVID-19
32339251 2020. The importance of hypertension as a risk factor for severe illness and mortality in COVID-19
32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
32241792 2020. COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
32354772 2020. Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
32332075 2020. Patients with lupus are not protected from COVID-19
32332072 2020. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
32295789 2020. Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19
32327426 2020. SLE patients are not immune to covid-19: importance of sending the right message across
32295787 2020. SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
32321720 2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)
32312768 2020. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
32245656 2020. COVID-19 in patients with cardiovascular diseases
32180426 2020. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes
32255510 2020. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement
32369656 2020. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding
32219995 2020. Safe delivery for pregnancies affected by COVID-19
32339382 2020. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis
32324956 2020. How should we treat pregnant women infected with SARS-CoV-2?
32340018 2020. Coronavirus Disease 2019 in a Hemodialysis Patient
32220865 2020. Non-steroidal anti-inflammatory drugs and covid-19
32205306 2020. Covid-19: European drugs agency to review safety of ibuprofen
32184201 2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
32253225 2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases
32369736 ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
32241880 2020. Drugs and the renin-angiotensin system in covid-19
32291262 2020. Covid-19: Black people and other minorities are hardest hit in US
32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32369606 2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience
32314798 2020. COVID-19 infection in patients with sickle cell disease
32333398 2020. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance
32312714 2020. COVID-19 More Frequent, Severe in Cancer Patients
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32302248 2020. ACEing COVID-19: A Role For Angiotensin Axis Inhibition in SARS-CoV-2 infection?
32302265 2020. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend
32377468 ä. First Case of an Infant with COVID-19 in the Middle East
32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
32282224 2020. COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations
32345646 2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte)
32286246 2020. COVID-19 infections are also affected by human ACE1 D/I polymorphism
32112082 2020. A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load
32220930 2020. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
32342637 2020. COVID-19 and obesity
32292054 2020. SARS-CoV-2 Infection in a 2-Week-Old Male With Neutropenia
32255491 2020. ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19
32320478 2020. Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence
32237261 ä. The COVID?19 outbreak and rheumatologic skin diseases
32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?
32375909 ä. Impact of Fundamental Diseases on Patients With COVID-19
32129518 ä. Angiotensin receptor blockers as tentative SARS?CoV?2 therapeutics
32233013 ä. Diabetes is a risk factor for the progression and prognosis of COVID?19
32374012 2020. Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries
32189428 ä. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID?19 in the general population?
32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study
32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
32356577 2020. Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration
32359088 2020. RAAS blockers in hypertension posing a higher risk towards the COVID-19
32362061 2020. (pat.on)Dupilumab and COVID-19: What should we expect?
32259611 2020. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
32356926 2020. Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19
32304146 2020. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections
32329083 2020. (ang.)COVID-19 transmission through host cell directed network of GPCR
32234728 2020. EMA advice on the use of NSAIDs for Covid-19
32295811 2020. EMA advice on renin-angiotensin system medicines during covid-19 pandemic
32357072 2020. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA
32376075 2020. Oligohydramnion in COVID19
32290680 2020. Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers
32310915 2020. ACE-inibitori, sartani e sindrome respiratoria acuta da coronavirus 2
32354990 2020. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
32239590 ä. Clinical findings in a patient with haemophilia A affected by COVID?19
32362297 ä. Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
32376422 ä. Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern
32380214 ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic
32245909 2020. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis
32312788 2020. Covid-19 infection in Crohn s disease under treatment with adalimumab
32307955 2020. COVID-19, THE KIDNEY AND HYPERTENSION
32220017 2020. Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient
32340044 2020. The ACE-2 in COVID-19: Foe or Friend?
32208987 2020. Renin-angiotensin system (RAS) blockers and the COVID-19 pandemic: at present there is no evidence to abandon RAS blockers
32367746 2020. ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The Pediatric Perspective
32348166 2020. Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
32324897 2020. Management of the first patient with confirmed COVID-19 in pregnancy in India: From guidelines to frontlines
32330287 2020. A systematic scoping review of COVID-19 during pregnancy and childbirth
32270479 2020. Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia
32271947 2020. Delivery in pregnant women infected with SARS-CoV-2: A fast review
32369616 2020. Critically ill pregnant patient with COVID-19 and neonatal death within two hours of birth
32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature
32255507 2020. COVID-19 and Older Adults: What We Know
32301766 ä. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2
32376098 ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS
32371817 2020. Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad?
32371814 2020. Response to four comments on ?Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic??
32371812 2020. COVID-19, hypertension and angiotensin receptor-blocking drugs
32371810 2020. Comment on ?Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic??
32345701 2020. The Immunocompromised Transplant Recipient and SARS-CoV-2 Infection
32317402 2020. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York
32312797 2020. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
32253888 2020. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection
32351121 2020. Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder
32353193 2020. Is the type of diabetes treatment relevant to outcome of COVID-19?
32162476 2020. Diabetes and COVID-19
32379925 2020. Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient
32379913 2020. Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs
32358791 2020. SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor
32330323 2020. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports
32294258 2020. SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor
32195824 2020. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
32242993 2020. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk
32354293 2020. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review
32222119 ä. Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia
32220066 ä. SARS?CoV?2 and HIV
32115733 ä. Coronavirus disease (COVID?19) and neonate: What neonatologist need to know
32160316 ä. Co?infection of SARS?CoV?2 and HIV in a patient in Wuhan city, China
32248565 ä. A twin challenge to handle: COVID?19 with pregnancy
32374416 2020. ACE2 and prognosis of COVID-19 Insights from Bartter s and Gitelman s syndromes patients
32369211 2020. What could be the better choice between ACE inhibitors and AT1R antagonists in coronavirus disease 2019 (COVID-19) patients?
32369203 2020. Smoking links to the severity of Covid-19: An update of a meta-analysis
32221983 2020. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
32266994 2020. Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19"
32266993 2020. Reporting of all cardiac medications and their outcome in COVID - 19
32352576 2020. COVID-19 in pregnancy: risk of adverse neonatal outcomes
32347975 2020. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey
32343410 2020. COVID-19 in Tuberculosis patients: a report of three cases
32330302 2020. Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"
32293753 2020. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis
32293709 2020. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better
32285949 2020. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19)
32374288 2020. Newborns at risk of COVID-19
32243919 2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab
